Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
1,5 USD | -4,46% | -10,18% | -16,28% |
Omzet 2022 | 42,01 mln. 38,61 mln. | Omzet 2023 | 39,55 mln. 36,35 mln. | Marktkapitalisatie | 26,7 mln. 24,54 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2022 | -5 mln. -4,59 mln. | Nettowinst (verlies) 2023 | -6 mln. -5,51 mln. | EV/omzet 2022 | 0,8 x |
Nettoschuld 2022 | 1,2 mln. 1,1 mln. | Nettoschuld 2023 | 107K 98,2K | EV/omzet 2023 | 0,68 x |
K/w-verhouding 2022 |
-5,88
x | K/w-verhouding 2023 |
-4,07
x | Werknemers | 91 |
Dividendrendement 2022 * |
-
| Dividendrendement 2023 |
-
| Vrij verhandelbaar | 55,99% |
Recentste transcriptie over Cumberland Pharmaceuticals Inc.
1 dag | -4,46% | ||
1 week | -10,18% | ||
Lopende maand | -6,25% | ||
1 maand | -3,23% | ||
3 maanden | -27,19% | ||
6 maanden | -7,98% | ||
Lopend jaar | -16,28% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
A. Kazimi
CEO | Chief Executive Officer | 65 | 07-01-99 |
John Hamm
DFI | Director of Finance/CFO | 67 | 01-01-19 |
James Herman
CMP | Compliance Officer | 67 | 01-01-03 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Martin Brown
BRD | Director/Board Member | 59 | 15-07-22 |
A. Kazimi
CEO | Chief Executive Officer | 65 | 07-01-99 |
Ken Krogulski
BRD | Director/Board Member | 66 | 18-01-17 |
Datum | Koers | Variatie | Volume |
---|---|---|---|
15-05-24 | 1,5 | -4,46% | 27 495 |
14-05-24 | 1,57 | -1,26% | 8 668 |
13-05-24 | 1,59 | +3,25% | 7 707 |
10-05-24 | 1,54 | -11,49% | 8 829 |
09-05-24 | 1,74 | +4,19% | 15 341 |
uitgestelde koers Nasdaq, 15 mei 2024 om 22:00 uur
Meer koersenVaira. 1 jan. | Kapi. | |
---|---|---|
-16,28% | 21,26 mln. | |
+21,28% | 43,92 mld. | |
+24,47% | 23,09 mld. | |
+19,22% | 15,35 mld. | |
+12,87% | 13,61 mld. | |
+44,67% | 12,02 mld. | |
-9,92% | 7 mld. | |
-0,05% | 6,79 mld. | |
-8,87% | 5,73 mld. | |
+13,07% | 5,6 mld. |